About This EventSanofi (Nasdaq: SNY) with We Are ILL, Inc., visits the Nasdaq MarketSite in Times Square. A patient advocacy organization, We Are ILL redefines what “sick” looks like by making the ...

IGM Biosciences (NASDAQ:IGMS) shares traded lower on Tuesday after Bank of America downgraded the micro-cap biotech to ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...

Sanofi (NASDAQ:SNY – Get Free Report) has been assigned an average recommendation of “Buy” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. Two research ...

Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of chlamydia infection. The company plans to begin a phase I/II study soon ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people ...

View Our Latest Stock Report on Sanofi Sanofi Stock Down 2.0 % Shares of NASDAQ:SNY opened at $54.34 on Tuesday. The company has a 50 day moving average price of $55.28 and a two-hundred day ...

Biotech company Regeneron (REGN) and French pharmaceutical giant Sanofi (SNY) today announced that Japan has granted ...

Pharmaceuticals stocks breathed a temporary sigh of relief after U.S. President Donald Trump spared the sector from the ambit ...

Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Sanofi (Nasdaq: SNY) with We Are ILL, Inc., visits the Nasdaq MarketSite in ...

In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against other best gene-editing stocks to buy. Gene editing is an advanced medical technique within gene therapy ...